News Archive

Dec 2017

Dec 21, 2017 VivaGel® BV treatment clinical submission under rolling submission

Nov 2017

Nov 29, 2017 AGM Chairman’s address and CEO presentation

Nov 21, 2017 NDA submission for Starpharma’s VivaGel® BV

Nov 21, 2017 NDA submission for VivaGel® BV in the US

Oct 2017

Oct 27, 2017 Notice of Annual General Meeting/Proxy Form

Oct 26, 2017 Appendix 4C – Quarterly Cashflow Report

Oct 25, 2017 Starpharma receives TGA marketing approval for VivaGel® BV

Oct 25, 2017 VivaGel® BV granted marketing approval in Australia

Oct 23, 2017 Morgans Under the Microscope Interview featuring Dr Jackie Fairley

Oct 18, 2017 Shareholder Update October 2017

Oct 09, 2017 Starpharma and Peter Mac Cancer Centre awarded DEP® Grant

Sep 2017

Sep 28, 2017 AstraZeneca presents first DEP® candidate as Bcl2/xL inhibitor

Sep 26, 2017 Starpharma reports positive phase 1 results

Sep 23, 2017 Starpharma rockets on cancer drug hope

Sep 22, 2017 DEP® docetaxel positive phase 1 results; phase 2 commences

Aug 2017

Aug 28, 2017 Starpharma featured on Sky Business News

Aug 28, 2017 Starpharma annual report and full year financial results

Aug 24, 2017 Starpharma to present at Finance News Network Investor Event

Aug 24, 2017 Starpharma CEO on Finance News Network

Aug 11, 2017 Seeking Alpha covers Starpharma

Aug 10, 2017 Starpharma and Monash awarded STEM+ Business fellowships

Aug 09, 2017 Hope is on the way for one of the world’s most common sexual problems

Aug 09, 2017 Starpharma readies US NDA for VivaGel® on positive results in Phase 3 Bacterial vaginosis

Aug 09, 2017 Starpharma and Monash awarded STEM+ Business Fellowships

Aug 07, 2017 Successful VivaGel® Phase 3 results and NDA planned for rBV

Aug 06, 2017 Biotech clinical trials a star performer

Jul 2017

Jul 19, 2017 Appendix 4C - Quarterly Cashflow Report

Jul 04, 2017 Shareholder Update July 2017

Jul 04, 2017 VivaGel® BV phase 3 results timing and commercialisation

Jun 2017

Jun 23, 2017 Starpharma’s sale of its agrochemical business and technology, expands Agrium’s tech base

Jun 20, 2017 Starpharma featured on Business IQ, Sky Business News

Jun 14, 2017 Finance News Network: Starpharma sells Agrochemicals business for $35M

Jun 14, 2017 Starpharma’s sale of its agrochemical business to Agrium for A$35M noted in The Land

Jun 14, 2017 Sale of Agrochemicals Business Investor Presentation

Jun 14, 2017 Starpharma sells Agrochemicals business to Agrium for $35M

Jun 06, 2017 DEP® irinotecan outperforms irinotecan in multiple cancer models

Jun 02, 2017 Starpharma receives DEP® milestone from AstraZeneca

Apr 2017

Apr 28, 2017 Appendix 4C - Quarterly Cashflow Report

Apr 20, 2017 Starpharma featured on Ticky on Sky Business News

Apr 20, 2017 AstraZeneca DEP® candidate advance triggers milestone to Starpharma

Apr 12, 2017 Melbourne-based company develops world's first anti-viral condom

Apr 12, 2017 Ansell launches VivaGel® condom in Canada

Mar 2017

Mar 30, 2017 VivaGel BV phase 3 trials for prevention of BV completed

Mar 30, 2017 VivaGel® BV phase 3 trials for prevention of BV completed

Feb 2017

Feb 27, 2017 Interim Report and Half-Yearly Financial Results

Jan 2017

Jan 31, 2017 Appendix 4C - Quarterly Cashflow Report

Jan 19, 2017 Shareholder Update January 2017

Jan 13, 2017 Starpharma VivaGel® BV gets FDA fast track

Jan 12, 2017 VivaGel® BV granted QIDP and Fast Track designation by US FDA